On Chief Executive Officer Clay Siegall’s blog, he has a story up about the thawing permafrost. There are fears that zombie viruses are lurking in this, frozen for centuries but still able to spread disease once sufficiently thawed. A bi outbreak of anthrax in Siberia, for instance, was the result of this virus being reintroduced through thawed permafrost that had lain dormant for many years. It spread from reindeer to people with dozens ending up hospitalized.
Another article on his blog shows that the flu can be a cause of heart attacks. Researchers say that you are six times more likely to have a heart attack when you have the flu than when you are well. This was the first study of its kind, although this connection had been long expected. The result of this research is that it is more important than ever to adequately protecting yourself by getting an annual flu shot although in some years that is more effective than others.
Dr. Clay Siegall of Seattle Genetics co-founded this company in 1998. He had years of experience researching cures for cancer before deciding that he would rather be the owner of his own company than work for someone else. As he puts it, he profits from his own ideas rather than the proceeds of his research ending up in some other executives pockets. He also has a lot more freedom do things the way he thinks they ought to be done, which isn’t generally possible when you work for someone else.
At Seattle Genetics Dr. Clay “Siegall has been very successful leading the company. In 2016, for instance, it was named one of the top 25 biotechnology companies in the world. His company focuses on using antibody-drug conjugates to create cures for cancer. Their first drug to be released was Adcetris and it is now sold worldwide in a partnership with Takeda Oncology Company out of Cambridge, Massachusetts. He took his company public in March 2001. It is traded on the Nasdaq under the stock ticker symbol SGEN.